查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1838445

2034 年生物製藥市場分析與預測：類型、產品、服務、技術、應用、最終用戶、流程、設備、材料類型和部署

Biologics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Device, Material Type, Deployment
出版日期: | 出版商: Global Insight Services | 英文 393 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物製藥市場預計將從 2024 年的 5.815 億美元增至 2034 年的 13.232 億美元，複合年成長率約為 8.6%。生物製藥市場包括源自生物來源，例如蛋白質、核酸和細胞。這些生物製藥對於治療癌症和自體免疫疾病等慢性疾病至關重要。生物技術的進步、慢性病的增加以及對個人化醫療日益成長的需求正在推動市場的發展。單株抗體、基因療法和生物相似藥的創新正在擴大治療選擇並提高療效。監管支持和戰略合作夥伴關係正在進一步推動市場成長，使生物製藥成為現代治療方法的基石。

在生物技術和個人化醫療進步的推動下，生物製藥市場正在強勁擴張。單株抗體市場因其在治療慢性病和癌症方面的有效性而成為領先的細分市場。重組蛋白緊隨其後，反映出它們在治療和疫苗中的應用日益廣泛。在基因工程和標靶治療技術進步的推動下，基因治療顯示出巨大的潛力。隨著幹細胞研究取得了有希望的治療成果，細胞治療正在獲得發展動能。由於需要品牌生物製劑的經濟高效的替代品，生物相似藥的重要性日益增加。這一趨勢正在推動人們轉向更易於獲得的醫療保健解決方案。市場對先進藥物輸送系統的需求也激增，這些系統可以提高生物製藥治療的療效和患者依從性。生物製藥公司之間的策略聯盟與合作正在促進創新並加速新型生物製劑的市場開發，為市場持續成長和豐厚利潤奠定基礎。

市場區隔
類型 單株抗體、疫苗、重組蛋白、基因治療、細胞治療、生物相似藥、血液製品、酶
產品 治療性蛋白質、抗體藥物複合體、細胞激素、融合蛋白、生長因子、荷爾蒙、干擾素、白細胞介素
服務 合約研究、契約製造、臨床試驗、監管服務、品質保證、供應鏈管理、物流
科技 DNA定序、CRISPR、合成生物學、生物加工、奈米技術、蛋白質工程、生物列印
目的 腫瘤科、感染疾病、自體免疫疾病、心血管疾病、代謝性疾病、神經內科、眼科、皮膚科
最終用戶 製藥公司、生技公司、研究機構、醫院、診所、診斷實驗室、學術機構
過程 上游工程、下​​游加工、配方、純化、發酵、細胞培養
裝置 生物反應器、離心機、層析法系統、過濾系統、混合系統
材料類型 蛋白質、抗體、核酸、細胞、病毒載體
部署 內部、外包、混合

市場概述

生物製藥繼續主導製藥行業，透過創新和成熟的治療方法佔據了相當大的市場佔有率。定價策略根據生產的複雜性和臨床療效而有所不同。新產品頻繁推出，反映了生物技術的進步以及單株治療方法、疫苗和基因療法的強大研發管線。對個人化醫療和標靶治療日益成長的需求正在推動市場發展。北美和歐洲是領先地區，而亞太地區由於醫療保健投資的增加和政府的支持政策而正在經歷加速成長。生物製藥市場競爭激烈，主要企業在大力投資研發以維持競爭優勢。監管起著至關重要的作用，嚴格的核准流程影響市場進入和擴張。 FDA 和 EMA 設定了高標準以確保安全性和有效性，這可能會延遲產品上市，但最終會增強市場信心。新興市場提供了有利可圖的機會，但駕馭不同的監管環境需要策略敏銳性。生物製藥的未來充滿希望，細胞和基因治療的進步推動著創新和市場發展。

主要趨勢和促進因素：

在生物技術進步和個人化醫療需求日益成長的推動下，生物製藥市場正經歷強勁成長。主要趨勢包括單株抗體、細胞和基因療法的興起，它們正在徹底改變各種疾病的治療模式。這些技術創新源自於對疾病機制和人類基因組的更深入理解。監管支援和快速核准途徑正在進一步加速市場擴張。世界各國政府都認知到生物製藥在滿足未滿足醫療需求方面的潛力，並正在簡化核准流程。此外，慢性病的流行和人口老化是主要促進因素，因此需要新的治療方案。生物製藥產業也大力投資研發。各公司正專注於擴大產能和改善藥物輸送系統。在醫療基礎設施不斷發展的新興市場中，機會無限。策略聯盟和夥伴關係日益盛行，使各公司得以利用互補優勢，擴大全球影響力。在持續創新和策略舉措的推動下，生物製藥市場可望持續成長。

限制與挑戰：

生物製藥市場目前面臨若干重大限制與挑戰。其中一個主要挑戰是生物製藥價格高昂，這限制了患者獲得藥物的機會，並給醫療保健系統帶來了經濟負擔。生物製藥的複雜製造過程需要在專業設施和技術人員方面進行大量投資，這進一步加劇了這個問題。此外，監管障礙也帶來了巨大的挑戰。嚴格的生物製劑核准程序導致時間過長和成本增加，阻礙了中小企業進入市場。智慧財產權問題也構成了重大障礙。專利到期為生物相似藥打開了大門，加劇了競爭並影響了市場佔有率。供應鏈中斷通常由地緣政治緊張局勢或全球健康危機引發，可能導致生物製劑短缺和分銷延遲。最後，對低溫運輸物流的需求進一步增加了複雜性和成本，阻礙了市場擴張，尤其是在資源匱乏的環境中。

主要企業

山德士、三星生物製劑、Biocon、康泰倫特、藥明生物製劑、龍沙、賽多利斯、勃林格殷格翰、富士迪奧辛斯生物技術、艾布澤納、AGC生物製劑、三星Bioepis、思拓凡、巴伐利亞北歐、MorphoSys

目錄

第1章生物製藥市場概述

  • 調查目的
  • 生物製藥市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章：生物製藥市場展望

  • 生物製藥市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章生物製藥市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章：生物製藥市場規模

  • 生物製藥市場規模（以價值計算）
  • 生物製藥市場規模（按數量）

第7章生物製藥市場（按類型）

  • 市場概況
  • 單株抗體
  • 疫苗
  • 重組蛋白
  • 基因治療
  • 細胞療法
  • 生物相似藥
  • 血液製品
  • 酵素
  • 其他

第8章生物製藥市場（按產品）

  • 市場概況
  • 治療性蛋白質
  • 抗體藥物複合體
  • 細胞激素
  • 融合蛋白
  • 生長因子
  • 荷爾蒙
  • 干擾素
  • 白細胞介素
  • 其他

第9章生物製藥市場（按服務）

  • 市場概況
  • 合約研究
  • 契約製造
  • 臨床試驗
  • 醫藥服務
  • 品質保證
  • 供應鏈管理
  • 物流
  • 其他

第 10 章 生物製藥市場（按技術）

  • 市場概況
  • DNA定序
  • CRISPR
  • 合成生物學
  • 生物過程
  • 奈米科技
  • 蛋白質工程
  • 生物列印
  • 其他

第11章生物製藥市場（依應用）

  • 市場概況
  • 腫瘤學
  • 感染疾病
  • 自體免疫疾病
  • 心血管疾病
  • 代謝紊亂
  • 神經病學
  • 眼科
  • 皮膚科
  • 其他

第 12 章生物製藥市場（依最終用戶）

  • 市場概況
  • 製藥公司
  • 生技公司
  • 研究所
  • 醫院
  • 診所
  • 診斷實驗室
  • 學術機構
  • 其他

第13章生物製藥市場（按製程）

  • 市場概況
  • 上游工程
  • 下游工藝
  • 配方
  • 純化
  • 發酵
  • 細胞培養
  • 其他

第14章生物製藥市場（按設備）

  • 市場概況
  • 生物反應器
  • 離心機
  • 層析法系統
  • 過濾系統
  • 混合系統
  • 其他

第 15 章。按材料類型分類的生物製藥市場

  • 市場概況
  • 蛋白質
  • 抗體
  • 核酸
  • 細胞
  • 病毒載體
  • 其他

第16章生物製藥市場（按部署）

  • 市場概況
  • 內部
  • 外包
  • 混合
  • 其他

第17章生物製藥市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章：公司簡介

  • Sandoz
  • Samsung Biologics
  • Biocon
  • Catalent
  • WuXi Biologics
  • Lonza
  • Sartorius
  • Boehringer Ingelheim
  • Fujifilm Diosynth Biotechnologies
  • Abzena
  • AGC Biologics
  • Samsung Bioepis
  • Cytiva
  • Bavarian Nordic
  • MorphoSys
簡介目錄
Product Code: GIS33678

Biologics Market is anticipated to expand from $581.5 million in 2024 to $1,323.2 million by 2034, growing at a CAGR of approximately 8.6%. The Biologics Market encompasses therapeutic products derived from living organisms, including proteins, nucleic acids, and cells. These biologics are pivotal in treating chronic diseases such as cancer and autoimmune disorders. The market is driven by advancements in biotechnology, increasing prevalence of chronic diseases, and rising demand for personalized medicine. Innovations in monoclonal antibodies, gene therapies, and biosimilars are expanding treatment options and enhancing efficacy. Regulatory support and strategic collaborations further propel market growth, positioning biologics as a cornerstone of modern therapeutics.

The Biologics Market is experiencing robust expansion, driven by advancements in biotechnology and personalized medicine. The monoclonal antibodies segment emerges as the top-performing sub-segment, owing to their efficacy in treating chronic diseases and cancer. Recombinant proteins follow closely, reflecting increased applications in therapeutic treatments and vaccines. Gene therapy showcases significant potential, propelled by innovations in genetic engineering and targeted treatments. The cell therapy sub-segment is gaining momentum, with stem cell research offering promising therapeutic outcomes. Biosimilars are becoming increasingly relevant, driven by the need for cost-effective alternatives to branded biologics. This trend is prompting a shift towards more accessible healthcare solutions. The market is also witnessing a surge in demand for advanced drug delivery systems, enhancing the efficacy and patient compliance of biologic treatments. Strategic partnerships and collaborations between biopharmaceutical companies are fostering innovation and accelerating the development of novel biologics, positioning the market for sustained growth and lucrative opportunities.

Market Segmentation
TypeMonoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy, Cell Therapy, Biosimilars, Blood Products, Enzymes
ProductTherapeutic Proteins, Antibody Drug Conjugates, Cytokines, Fusion Proteins, Growth Factors, Hormones, Interferons, Interleukins
ServicesContract Research, Contract Manufacturing, Clinical Trials, Regulatory Services, Quality Assurance, Supply Chain Management, Logistics
TechnologyDNA Sequencing, CRISPR, Synthetic Biology, Bioprocessing, Nanotechnology, Protein Engineering, Bioprinting
ApplicationOncology, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Disorders, Neurology, Ophthalmology, Dermatology
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Hospitals, Clinics, Diagnostic Labs, Academic Institutions
ProcessUpstream Processing, Downstream Processing, Formulation, Purification, Fermentation, Cell Culture
DeviceBioreactors, Centrifuges, Chromatography Systems, Filtration Systems, Mixing Systems
Material TypeProteins, Antibodies, Nucleic Acids, Cells, Viral Vectors
DeploymentIn-house, Outsourced, Hybrid

Market Snapshot:

Biologics continue to dominate the pharmaceutical landscape, with significant market share held by innovative therapies and established treatments. Pricing strategies vary, driven by the complexity of production and clinical efficacy. New product launches are frequent, reflecting advancements in biotechnology and a robust pipeline of monoclonal antibodies, vaccines, and gene therapies. The market is buoyed by increasing demand for personalized medicine and targeted therapies. North America and Europe are key regions, though Asia-Pacific is witnessing accelerated growth due to rising healthcare investments and supportive government policies. Competition in the biologics market is intense, with leading companies investing heavily in R&D to maintain their competitive edge. Regulatory influences play a pivotal role, with stringent approval processes impacting market entry and expansion. The FDA and EMA set high standards, ensuring safety and efficacy, which can delay product launches but ultimately enhance market credibility. Emerging markets offer lucrative opportunities, yet navigating diverse regulatory landscapes requires strategic acumen. Biologics' future is promising, with advancements in cell and gene therapies driving innovation and market evolution.

Geographical Overview:

The biologics market is witnessing robust growth across diverse regions, each presenting unique opportunities. North America retains a dominant position, bolstered by advanced healthcare infrastructure and significant R&D investments. The presence of leading biopharmaceutical firms further drives innovation and market expansion. Europe follows, with its strong emphasis on biotechnology research and favorable regulatory frameworks enhancing market dynamics. The Asia Pacific region is experiencing rapid market growth, driven by an increasing prevalence of chronic diseases and rising healthcare expenditure. Countries like China and India are emerging as lucrative markets due to their large patient populations and government support for biotechnology. Latin America presents promising growth prospects, with Brazil and Mexico investing in healthcare advancements. The Middle East & Africa region is gradually gaining traction, with countries like the UAE and South Africa recognizing the potential of biologics in improving healthcare outcomes. These emerging markets offer significant opportunities for expansion and investment in the biologics sector.

Key Trends and Drivers:

The biologics market is experiencing robust growth, fueled by advancements in biotechnology and increased demand for personalized medicine. Key trends include the rise of monoclonal antibodies and cell and gene therapies, which are revolutionizing treatment paradigms across various diseases. These innovations are driven by a deeper understanding of disease mechanisms and the human genome. Regulatory support and expedited approval pathways are further accelerating market expansion. Governments are recognizing the potential of biologics to address unmet medical needs, thus streamlining approval processes. Additionally, the increasing prevalence of chronic diseases and aging populations are significant drivers, necessitating novel therapeutic solutions. The biopharmaceutical industry is also witnessing substantial investments in research and development. Companies are focusing on enhancing production capabilities and improving drug delivery systems. Opportunities abound in emerging markets, where healthcare infrastructure is evolving. Strategic collaborations and partnerships are becoming prevalent, enabling firms to leverage complementary strengths and expand their global footprint. The biologics market is poised for sustained growth, driven by continuous innovation and strategic initiatives.

Restraints and Challenges:

The biologics market is currently encountering several significant restraints and challenges. One of the primary challenges is the high cost of biologic drugs, which limits accessibility for patients and places a financial burden on healthcare systems. The complexity of manufacturing processes for biologics further exacerbates this issue, as it requires significant investment in specialized facilities and skilled personnel. Additionally, regulatory hurdles present another formidable challenge. The stringent approval processes for biologics can lead to prolonged timelines and increased costs, discouraging smaller companies from entering the market. Intellectual property concerns also pose a significant barrier, as patent expirations open the door to biosimilars, intensifying competition and impacting market share. Supply chain disruptions, often caused by geopolitical tensions or global health crises, can lead to shortages and delays in the distribution of biologics. Lastly, the need for cold chain logistics adds another layer of complexity and cost, hindering market expansion, particularly in low-resource settings.

Key Players:

Sandoz, Samsung Biologics, Biocon, Catalent, WuXi Biologics, Lonza, Sartorius, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, Abzena, AGC Biologics, Samsung Bioepis, Cytiva, Bavarian Nordic, MorphoSys

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biologics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biologics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Material Type
  • 2.12 Key Highlights of the Market, by Deployment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Material Type
  • 3.11 Market Attractiveness Analysis, by Deployment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biologics Market Outlook

  • 4.1 Biologics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biologics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biologics Market Size

  • 6.1 Biologics Market Size, by Value
  • 6.2 Biologics Market Size, by Volume

7: Biologics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Recombinant Proteins
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Gene Therapy
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Biosimilars
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Blood Products
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Enzymes
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Biologics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Proteins
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Antibody Drug Conjugates
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cytokines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Fusion Proteins
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Growth Factors
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Hormones
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Interferons
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Interleukins
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Biologics Market, by Services

  • 9.1 Market Overview
  • 9.2 Contract Research
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Contract Manufacturing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Clinical Trials
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Quality Assurance
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Supply Chain Management
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Logistics
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Biologics Market, by Technology

  • 10.1 Market Overview
  • 10.2 DNA Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Synthetic Biology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bioprocessing
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Nanotechnology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Protein Engineering
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Bioprinting
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Biologics Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Infectious Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Autoimmune Diseases
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiovascular Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Metabolic Disorders
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Neurology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Ophthalmology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Dermatology
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region
  • 11.10 Others
    • 11.10.1 Key Market Trends & Opportunity Analysis
    • 11.10.2 Market Size and Forecast, by Region

12: Biologics Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Hospitals
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Clinics
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Diagnostic Labs
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Academic Institutions
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region
  • 12.9 Others
    • 12.9.1 Key Market Trends & Opportunity Analysis
    • 12.9.2 Market Size and Forecast, by Region

13: Biologics Market, by Process

  • 13.1 Market Overview
  • 13.2 Upstream Processing
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Downstream Processing
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Formulation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Purification
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Fermentation
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Cell Culture
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Biologics Market, by Device

  • 14.1 Market Overview
  • 14.2 Bioreactors
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Centrifuges
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Chromatography Systems
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Filtration Systems
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Mixing Systems
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Biologics Market, by Material Type

  • 15.1 Market Overview
  • 15.2 Proteins
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Antibodies
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Nucleic Acids
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Cells
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Viral Vectors
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region
  • 15.7 Others
    • 15.7.1 Key Market Trends & Opportunity Analysis
    • 15.7.2 Market Size and Forecast, by Region

16: Biologics Market, by Deployment

  • 16.1 Market Overview
  • 16.2 In-house
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Outsourced
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Hybrid
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Biologics Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Device
    • 17.2.10 North America Market Size and Forecast, by Material Type
    • 17.2.11 North America Market Size and Forecast, by Deployment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Device
      • 17.2.9.9 United States Market Size and Forecast, by Material Type
      • 17.2.9.10 United States Market Size and Forecast, by Deployment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Device
      • 17.2.10.9 Canada Market Size and Forecast, by Material Type
      • 17.2.10.10 Canada Market Size and Forecast, by Deployment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Device
    • 17.3.10 Europe Market Size and Forecast, by Material Type
    • 17.3.11 Europe Market Size and Forecast, by Deployment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Device
      • 17.3.10.9 Germany Market Size and Forecast, by Material Type
      • 17.3.10.10 Germany Market Size and Forecast, by Deployment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Device
      • 17.3.11.9 France Market Size and Forecast, by Material Type
      • 17.3.11.10 France Market Size and Forecast, by Deployment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Device
      • 17.3.12.9 Spain Market Size and Forecast, by Material Type
      • 17.3.12.10 Spain Market Size and Forecast, by Deployment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Device
      • 17.3.13.9 Italy Market Size and Forecast, by Material Type
      • 17.3.13.10 Italy Market Size and Forecast, by Deployment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Device
      • 17.3.14.9 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.10 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Device
      • 17.3.15.9 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.10 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Device
      • 17.3.16.9 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.10 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Device
      • 17.3.17.9 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.10 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Device
      • 17.3.18.9 Finland Market Size and Forecast, by Material Type
      • 17.3.18.10 Finland Market Size and Forecast, by Deployment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Device
      • 17.3.19.9 Russia Market Size and Forecast, by Material Type
      • 17.3.19.10 Russia Market Size and Forecast, by Deployment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Device
      • 17.4.9.9 China Market Size and Forecast, by Material Type
      • 17.4.9.10 China Market Size and Forecast, by Deployment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Device
      • 17.4.10.9 India Market Size and Forecast, by Material Type
      • 17.4.10.10 India Market Size and Forecast, by Deployment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Device
      • 17.4.11.9 Japan Market Size and Forecast, by Material Type
      • 17.4.11.10 Japan Market Size and Forecast, by Deployment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Device
      • 17.4.12.9 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.10 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Device
      • 17.4.13.9 Australia Market Size and Forecast, by Material Type
      • 17.4.13.10 Australia Market Size and Forecast, by Deployment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Device
      • 17.4.14.9 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.10 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Device
      • 17.4.15.9 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.10 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Device
      • 17.4.16.9 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.10 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Device
      • 17.4.17.9 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.10 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Device
    • 17.5.10 Latin America Market Size and Forecast, by Material Type
    • 17.5.11 Latin America Market Size and Forecast, by Deployment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Device
      • 17.5.9.9 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.10 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Device
      • 17.5.10.9 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.10 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Device
      • 17.5.11.9 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.10 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Device
      • 17.6.10.9 UAE Market Size and Forecast, by Material Type
      • 17.6.10.10 UAE Market Size and Forecast, by Deployment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Device
      • 17.6.11.9 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.10 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Sandoz
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Samsung Biologics
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Biocon
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Catalent
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 WuXi Biologics
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Lonza
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sartorius
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Boehringer Ingelheim
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fujifilm Diosynth Biotechnologies
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Abzena
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 AGC Biologics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Samsung Bioepis
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Cytiva
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Bavarian Nordic
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 MorphoSys
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis